XML 53 R38.htm IDEA: XBRL DOCUMENT v3.25.2
Acquisitions, Divestitures and Strategic Investments - Level 3 Contingent Consideration (Details) - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Business Combination [Line Items]    
Fair value of contingent consideration $ 367 $ 171
Revenue-based Payments and Commercialization Milestones | Discount Rate    
Business Combination [Line Items]    
Fair value of contingent consideration $ 129  
Revenue-based Payments and Commercialization Milestones | Discount Rate | Minimum    
Business Combination [Line Items]    
Risk-Adjusted Discount Rates used in Purchase Price Allocation 6.00%  
Probability of Payment 30.00%  
Revenue-based Payments and Commercialization Milestones | Discount Rate | Maximum    
Business Combination [Line Items]    
Risk-Adjusted Discount Rates used in Purchase Price Allocation 15.00%  
Probability of Payment 100.00%  
Revenue-based Payments and Commercialization Milestones | Discount Rate | Weighted Average    
Business Combination [Line Items]    
Risk-Adjusted Discount Rates used in Purchase Price Allocation 9.00%  
Probability of Payment 95.00%  
Clinical-based, Regulatory and Other Milestones | Discount Rate    
Business Combination [Line Items]    
Fair value of contingent consideration $ 238  
Clinical-based, Regulatory and Other Milestones | Discount Rate | Minimum    
Business Combination [Line Items]    
Risk-Adjusted Discount Rates used in Purchase Price Allocation 4.00%  
Probability of Payment 74.00%  
Clinical-based, Regulatory and Other Milestones | Discount Rate | Maximum    
Business Combination [Line Items]    
Risk-Adjusted Discount Rates used in Purchase Price Allocation 5.00%  
Probability of Payment 86.00%  
Clinical-based, Regulatory and Other Milestones | Discount Rate | Weighted Average    
Business Combination [Line Items]    
Risk-Adjusted Discount Rates used in Purchase Price Allocation 5.00%  
Probability of Payment 80.00%